Literature DB >> 32907829

Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor.

Chun-Ying Wu1,2, Hsiu J Ho3, Chen-Yi Wu4, Yi-Ju Chen5, Teng-Yu Lee6, Yao-Chun Hsu7, Jaw-Town Lin8.   

Abstract

Entities:  

Keywords:  antibody targeted therapy; hepatoma; proton pump inhibition

Year:  2020        PMID: 32907829     DOI: 10.1136/gutjnl-2020-321932

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  1 in total

Review 1.  Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper.

Authors:  Jean-Luc Raoul; Julien Edeline; Victor Simmet; Camille Moreau-Bachelard; Marine Gilabert; Jean-Sébastien Frénel
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.